Study about the association between anticaridolipin antibodies and peripheral vascular phenomena in patients suffering from systemic scleroderma;Estudo de associação entre anticorpos anticardiolipinas e fenômenos vasculares periféricos em pacientes com esclerodermia sistêmica

Anais Brasileiros de Dermatologia

Volumn 85, Issue 3, 2010, Pages 403-405

  Liberati, Ana Paula Torres ^a   Ribeiro, Camila Ferrari ^a   Skare, Thelma ^a,b  

^a University Evangelic Hospital of Curitiba   (Brazil)

^b University Evangelic Hospital/Evangelic Faculty of Parana   (Brazil)

Author keywords

Limited; Scleroderma, diffuse; Skin ulcer

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; RAYNAUD PHENOMENON; SCAR; SYSTEMIC SCLEROSIS; TELANGIECTASIA; THROMBOEMBOLISM; THROMBOSIS; VASCULAR DISEASE; VASOSPASM; BLOOD; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; SCLERODERMA, SYSTEMIC;

EID: 77955637990     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962010000300022     Document Type: Article

References (8)

1. Mayes M. Systemic sclerosis: clinical features. In: Klipel J, Stone J, Crofford L, White P, eds. Primer on rheumatic diseases. New York: Springer; 2008. p.343-58.
2. Marie I, Jouen F, Hellot M, Levesque H. Anticardiolipin and anti-beta-2 glycoprotein 1 antibodies and lupus like anticoagulant: prevalence and significance in systemic sclerosis. Br J Dermatol. 2008;158:141-4. (Pubitemid 350221924)
3. Xu S, Denton C, Holmes A, Dashwood M, Abraham D, Black C. Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts. J Cardiovasc Pharmacol. 1998;31Suppl 1:S360-3. (Pubitemid 128709951)
4. Assous N, Allanore Y, Batteux F, Meune C, Toulon P, Weill B, et al. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol. 2005;23:199-204. (Pubitemid 40663000)
5. Santamaria JR, Badziak D, de Barros MF, Manderlli FL, Cavalin LC, Sato MS. Síndrome antifosfolipide. An Bras Dermatol 2005;80:225-39.
6. Petri M. Clinical and management aspects of antiphospholipid antibody syndrome. In: Wallace D, Hahn B, eds. Dubois' Lupus erythematosus. Philadelphia: Willians & Wilkins; 2007. p.1262-97.
7. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:281-90.
8. Goldberg SN, Conti-Kelly AM, Greco TP. A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med. 1995;98:473-9.